Baylor Scott & White Health-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Baylor Scott & White Health - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014280
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:51
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Baylor Scott & White Health (Baylor Scott & White) is a non-profit organization that provides medical care services. The organization provides medical education, medical services and conducts medical research. It offers medical services in the area of emergency care, cancer care, behavioral and psychological health, heart health, breast care, body composition analysis, cholesterol, blood pressure, pediatric care and primary care, among others. The organization conducts its research through various institutes and centers. It has operations across the US. Baylor Scott & White is headquartered in Dallas, Texas, the US.

Baylor Scott & White Health – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Baylor Scott & White Health, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Baylor Scott & White Health, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Baylor Scott & White Health, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Baylor Scott & White Health, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Baylor Scott & White Health, Medical Devices Deals, 2011 to YTD 2017 10
Baylor Scott & White Health, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Baylor Scott & White Health, Pharmaceuticals & Healthcare, Deal Details 13
Partnerships 13
Baylor Research Enters into Licensing Agreement with Swedish Orphan Biovitrum 13
Baylor Scott & White Health Forms Joint Venture with AccentCare 14
Abzena and Baylor Scott & White Research Institute Form Joint Venture 15
Baylor College of Medicine Enters into Research Agreement with Baylor Scott & White Health 16
TGen Enters into Research Agreement with Baylor Research Institute 17
Antitope Extends Research Agreement with ANRS, INSERM and Baylor Research Institute 18
Roche, ANRS, Baylor Researh Institute And Inserm Transfert Enter Into Co-Development Agreement For Therapeutic Vaccines 19
Baylor Research Enters Into Co-Development Agreement With Eureka Genomics 21
Licensing Agreements 22
Ultragenyx Pharma Expands Licensing Agreement With Baylor Research Institute For Triheptanoin 22
Ultragenyx Pharma Enters Into Licensing Agreement With Baylor Research Institute For Triheptanoin 23
Baylor Scott & White Health – Key Competitors 24
Baylor Scott & White Health – Key Employees 25
Baylor Scott & White Health – Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Recent Developments 27
Strategy And Business Planning 27
Apr 10, 2017: Baylor Scott & White Health Opening Austin-Area Westlake Clinic 27
Mar 30, 2017: Baylor Scott & White Health Convenient Care Clinics to Open across Dallas-Fort Worth Area in Tom Thumb Stores 28
Mar 29, 2017: Baylor Scott & White Health Opening Kyle, Texas, Clinic 29
Feb 22, 2017: Baylor Scott & White Health Opens Cancer Center in College Station 30
Feb 08, 2017: Baylor Scott & White Health Increasing Health and Wellness Options with New Medical Center in Pflugerville 31
Jan 17, 2017: Baylor Scott & White Health Opening Austin-Area Primary Care Clinics, Offering App-Based Care Delivery Downtown 32
Jan 04, 2017: New Retail Pharmacy Opens Inside the Baylor Scott & White Medical Center – College Station 33
Corporate Communications 34
Nov 07, 2017: Baylor Scott & White Health Strengthens Executive Leadership Team with New Hire and Promotions 34
Oct 10, 2016: Baylor Scott & White Health Announces Jim Hinton as New President and CEO 36
Legal and Regulatory 38
Jan 13, 2017: Baylor Scott & White Charles A. Sammons Cancer Center – McKinney Accredited by the Commission on Cancer of the American College of Surgeons 38
Dec 05, 2016: Baylor Scott & White Hospitals Earn Texas Ten Step Designation 39
Government and Public Interest 40
Mar 29, 2017: Study Identifies Gene Mutation that Boosts Aspirin’s Cancer Prevention Benefits 40
Mar 06, 2017: New Colon Cancer Biomarkers May Guide Development of Personalized Treatment 41
Feb 13, 2017: Dallas Researchers Identify How Common Gut Bacteria May Cause Colon Cancer 42
Oct 10, 2016: Grant for Cancer Research Means More Cancer Drugs in the Pipeline Faster 43
Oct 10, 2016: Common Asthma Drug Could Prevent Liver Disease, Reduce Need for Liver Transplants 44
Product News 45
Oct 14, 2016: Dallas Researchers Develop First-Ever Tuberculosis Treatment Regimen for Children 45
Mar 03, 2017: Baylor Scott White Health Introduces Robotic-Assisted Cardiac Catheterization Technology to DFW 46
Other Significant Developments 47
Jul 13, 2017: Baylor Scott & White Health Selects Kyruus’ Solutions to Enhance Provider Data Management and Patient Access 47
Mar 28, 2017: The Heart Hospital Baylor Plano Performs First Robotic-Assisted Peripheral Intervention in Texas 48
Mar 13, 2017: Baylor Scott & White Cancer Center – College Station Brings Care Where it’s Needed Most 49
Appendix 51
Methodology 51
About GlobalData 51
Contact Us 51
Disclaimer 51

List of Tables
Baylor Scott & White Health, Pharmaceuticals & Healthcare, Key Facts 2
Baylor Scott & White Health, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Baylor Scott & White Health, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Baylor Scott & White Health, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Baylor Scott & White Health, Deals By Therapy Area, 2011 to YTD 2017 9
Baylor Scott & White Health, Medical Devices Deals, 2011 to YTD 2017 10
Baylor Scott & White Health, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Baylor Research Enters into Licensing Agreement with Swedish Orphan Biovitrum 13
Baylor Scott & White Health Forms Joint Venture with AccentCare 14
Abzena and Baylor Scott & White Research Institute Form Joint Venture 15
Baylor College of Medicine Enters into Research Agreement with Baylor Scott & White Health 16
TGen Enters into Research Agreement with Baylor Research Institute 17
Antitope Extends Research Agreement with ANRS, INSERM and Baylor Research Institute 18
Roche, ANRS, Baylor Researh Institute And Inserm Transfert Enter Into Co-Development Agreement For Therapeutic Vaccines 19
Baylor Research Enters Into Co-Development Agreement With Eureka Genomics 21
Ultragenyx Pharma Expands Licensing Agreement With Baylor Research Institute For Triheptanoin 22
Ultragenyx Pharma Enters Into Licensing Agreement With Baylor Research Institute For Triheptanoin 23
Baylor Scott & White Health, Key Competitors 24
Baylor Scott & White Health, Key Employees 25
Baylor Scott & White Health, Subsidiaries 26

★海外企業調査レポート[Baylor Scott & White Health-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Dataprep Holdings Bhd (DATAPRP):企業の財務・戦略的SWOT分析
    Dataprep Holdings Bhd (DATAPRP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Dubai Electricity and Water Authority:企業の発電所・SWOT分析2018
    Dubai Electricity and Water Authority - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, informatio …
  • Bunzl plc (BNZL)-医療機器分野:企業M&A・提携分析
    Summary Bunzl plc (Bunzl) is a global distribution and outsourcing company that supplies a broad range of non-food products to a diverse market sectors. The company offers an array of food packaging, disposable tableware and catering equipment, cleaning and hygiene supplies, guest amenities, persona …
  • Avon Products, Inc.:企業の戦略・SWOT・財務情報
    Avon Products, Inc. - Strategy, SWOT and Corporate Finance Report Summary Avon Products, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Ingredion Incorporated:企業の戦略・SWOT・財務情報
    Ingredion Incorporated - Strategy, SWOT and Corporate Finance Report Summary Ingredion Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • EOS imaging SA (EOSI):医療機器:M&Aディール及び事業提携情報
    Summary EOS imaging SA (EOS Imaging) is an orthopedic imaging company that designs, develops, and markets EOS patented medical imaging system. EOS captures whole body images of a standing patient in a single scan without any stitching or vertical distortion. Through EOS, the company provides the ful …
  • Downer EDI Ltd (DOW):企業の財務・戦略的SWOT分析
    Downer EDI Ltd (DOW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Manhattan Associates Inc (MANH):企業の財務・戦略的SWOT分析
    Manhattan Associates Inc (MANH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Avery Dennison Corporation (AVY):企業の財務・戦略的SWOT分析
    Avery Dennison Corporation (AVY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Sojitz Corp (2768):企業の財務・戦略的SWOT分析
    Sojitz Corp (2768) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • EyePoint Pharmaceuticals Inc (PSDV):医療機器:M&Aディール及び事業提携情報
    Summary EyePoint Pharmaceuticals Inc (EyePoint), formerly pSivida Corp, is a biopharmaceutical company that provides development of miniaturized, sustained-release drug delivery products and technologies. The company offers products such as iluvien, retisert and durasert, among others. Its durasert …
  • Bank of Queensland Ltd (BOQ):企業の財務・戦略的SWOT分析
    Bank of Queensland Ltd (BOQ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Vale Canada Ltd:企業の戦略・SWOT・財務情報
    Vale Canada Ltd - Strategy, SWOT and Corporate Finance Report Summary Vale Canada Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • ElectroCore Inc (ECOR):医療機器:M&Aディール及び事業提携情報
    Summary ElectroCore Inc (ElectroCore) is a bioelectronic medicine healthcare company. The company engaged in developing vagus nerve stimulation non-invasively (nVNS) therapy for neurology and rheumatology. It primarily focused on headache such as episodic cluster headache, migraine, and posttraumati …
  • Petroleo Brasileiro SA:企業の戦略・SWOT・財務分析
    Petroleo Brasileiro SA - Strategy, SWOT and Corporate Finance Report Summary Petroleo Brasileiro SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • LG International Corp (001120):企業の財務・戦略的SWOT分析
    LG International Corp (001120) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Yokogawa Electric Corp (6841):石油・ガス:M&Aディール及び事業提携情報
    Summary Yokogawa Electric Corp (Yokogawa) is an industrial automation company. It manufactures and supplies products and solutions in measurement, control, and information technologies fields. The company’s product offering include differential pressure/pressure transmitters, flow meters, and proces …
  • Australian Postal Corporation:企業の戦略的SWOT分析
    Australian Postal Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Zurich Insurance Group Ltd:企業の戦略・SWOT・財務情報
    Zurich Insurance Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Zurich Insurance Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Elsalys Biotech SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Elsalys Biotech SA (Elsalys Biotech) is a pharmaceutical company that develops new generation antibodies to modulate the immune system of patients with cancer or rare haematological diseases. The company's pipeline programs include anti-CD160, for macular degeneration or certain retinopathie …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆